Somaxon Pharmaceuticals, Inc. (SOMX) Posts Q2 EPS Loss of $0.33,
Tweet
Share
E-mailGet Alerts SOMX Hot Sheet
Price: $3.00 --0%
Financial Fact:
Research and development: 0
Today's EPS Names:
SUNE, NSLR, OCTV, More
Financial Fact:
Research and development: 0
Today's EPS Names:
SUNE, NSLR, OCTV, More
Join SI Premium – FREE
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) reported Q2 EPS of ($0.33), $0.03 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $3.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Avino Silver & Gold Mines (ASM) Misses Q2 EPS by 4c
- Riskified Ltd. (RSKD) Reports In-Line Q2 EPS ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
